New powdered plasma shows promise in early safety trial
Disease control
Completed
This early study tested the safety of a new spray-dried plasma product called FrontlineODP in 24 healthy volunteers. Participants received increasing doses (1 to 4 units) to see if it causes side effects. The goal is to develop a shelf-stable plasma that can be stored at room tem…
Phase: PHASE1 • Sponsor: Velico Medical • Aim: Disease control
Last updated Jun 26, 2026 17:56 UTC